Door to Balloon Time: Does it Matter? Tale of Two Studies.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality.
Advertisements

Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
Guidelines recommend consideration of fibrinolytic therapy if unable to achieve a door to balloon time ≤120 minutes for STEMI patients transferred for.
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
“Influence of Stroke Subtype on Quality of Care in The Get With The Guidelines-Stroke Program” Eric E. Smith, MD, MPH; Li Liang PhD; Adrian F Hernandez,
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Valsartan Antihypertensive Long-Term Use Evaluation Results
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
OVERALL CATHETERIZATION LABORATORY NORMAL ANGIOGRAPHY RATE DOES NOT INCREASE WITH EMERGENCY ROOM ACTIVATION OF PRIMARY CORONARY INTERVENTION (PCI) FOR.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Clinical Trial Results. org Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis.
Primary PCI Treatment of choice for Acute MI.
Masoudi FA et al J Am Coll Cardiol (Published online 27 November 2008) CVN Weekly Interventional Update December 8, 2008 Jeffrey J. Popma and Christopher.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Author Disclosures Differences in Implantation-Related Adverse Events Between Men and Women Receiving ICD Therapy for Primary Prevention Differences in.
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
ACTION Registry-GWTG Results: January 1, 2009 – December 31, 2009.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
Gregg W. Stone, Tim Clayton, Roxana Mehran, Efthymios N. Deliargyris, Jayne Prats, Stuart J. Pocock TCT 2012; JACC 2012;60(17SupplB):B16 The HORIZONS-AMI.
Comparing Hospital Performance in Door-to-Balloon Time Between the Hospital Quality Alliance and the National Cardiovascular Data Registry Brahmajee K.
Decreasing Incidence of Cardiogenic Shock Summary and Comment by J. Stephen Bohan, MD, MS, FACP, FACEP Published in Journal Watch Emergency Medicine December.
BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced.
Gregg W. Stone, Tim Clayton, Roxana Mehran, Efthymios N. Deliargyris, Jayne Prats, Stuart J. Pocock Bivalirudin Reduces Cardiac Mortality in Patients with.
IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 Bimal R. Shah,
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
BACKGROUND: COMPARATIVE ANALYSIS OF MORPHOLOGICAL EKG CHANGES AND DOOR-TO-BALLOON TIME IN STEMI Mercy P. Chandrasekaran, Jeffrey Cook, Raj Marok, Carlos.
Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Author Disclosure Sex Differences in the Characteristics of Patients Receiving ICD Therapy for the Primary Prevention of Sudden Cardiac Death –Stacie L.
Associate Professor, Honorary Consultant Cardiologist
Total Occlusion Study of Canada (TOSCA-2) Trial
Eva Kline-Rogers RN, NP, AACC University of Michigan
STEMI Systems of Care – Update on Mission: Lifeline:
Akshay Bagai MD, MHS St. Michael’s Hospital, Toronto, Canada
Mortality Related to Periprocedural MI in CTO-PCI
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
Singapore’s Experience in Primary PCI in the Last Ten Years
Fort Hays State University, Department of Nursing
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
Fewer PCIs After Public Reporting Changes in NY
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
Global Registry of Acute Coronary Events: GRACE
Circulation 2001;104: Circulation 2001;104:
An example of the Lancet
National trends in hospital length of stay for acute myocardial infarction in China
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Presentation transcript:

Door to Balloon Time: Does it Matter? Tale of Two Studies

Relationship of D2B Time and Mortality, Rathore BMJ 2009 Median D3B time 83 min, with 58% < 90 min Mortality decreases until D2B <45-60 min

Background NEJM 2013 Primary PCI is the preferred treatment for acute STEMI Previous observational studies have shown a strong association between D2B time and reduced mortality Led to current clinical practice guidelines from the ACC and AHA to recommend a D2B time of ≤90 minutes Because of this recommendation, D2B time has become: – focus of local, regional, and national quality-improvement initiatives – currently tracked by a number of clinical registries – has evolved into a key quality metric – also have financial implications, since now tied to CMS reimbursement

Background (2) NEJM 2013 Unknown whether D2B improvements are associated with reduced mortality Some studies found that mortality did not decrease among patients undergoing primary PCI, despite large reductions in D2B times – Study limited to regional results – may have lacked sufficient power to detect a survival benefit related to the improved treatment times Purpose of the study: to determine if shorter D2B times are associated with a decrease in in-hospital mortality among patients undergoing primary PCI for STEMI

Results (1) Patient Population A total of 95,007 patients from 515 hospitals undergoing primary PCI from 7/05-6/09 Mean age was 60.8 years; 28% of the patients were women. Prevalence of RF (DM, HTN, inc chol), prior MI, prior PCI increased each year Overall 9.9% of pts presented with cardiogenic shock which remained relatively constant The median D2B time decreased significantly each year: – 83 minutes in 2005–2006 – 67 minutes in 2008–2009 (P<0.001).

In-Hospital Mortality Overall in-hospital mortality was unchanged during the course of the study Menees DS et al. N Engl J Med 2013;369:

Results (3) The percent of pts with a D2B time ≤90 minutes increased from 60% to 83% over the course of the study (P<0.001) Unadjusted mortality for pts with D2B ≤90 minutes remained constant at 3.7% (P=0.40 for trend)

Results (4) The percent of pts with a D2B time of >90 minutes decreased from 40% to 17% Unadjusted mortality increased for pts with D2B time >90 minutes from 6.5% in the first year to 8.9% in the last (P<0.001) Unadjusted mortality was lower among ptswith a D2B time 90 minutes (3.7% vs. 7.3%, P<0.001)

Door-to-Balloon Times and Mortality Overall and High-Risk Subgroups, 2005 to 2009 Menees DS et al. N Engl J Med 2013;369:

Results (5) No significant change in mortality was observed in any of the prespecified high-risk subgroups – patients >75 (P=0.19) – anterior myocardial infarction (P=0.79) – cardiogenic shock (P=0.60) In a risk-adjusted analysis, no significant change in in- hospital mortality – 5.0% in 2005–2006 – 4.7% in 2008–2009 (P=0.34) After adjustment, no significant association between the annual reduction in D2B time and mortality (OR for a 10- minute reduction in D2B time, 1.04; 95% CI, 0.99 to 1.09; P=0.17).

Limitations Time interval differences may have been too short to show significant differences Did not account for changes in: – Population demographics – Increase in use of primary PCI – Increase in use of primary PCI in cardiac arrest patients D2B time only one component of total ischemic time

Bates ER, Jacobs AK. N Engl J Med 2013;369:

Lancet, Online Nov 2014

Background Hypothesis was that the changing population of patients undergoing pPCI contributed to trends toward an increasing mortality risk, despite consistently lower mortality in individual patients with shorter D2B times. Used multilevel models: – Allow for the individual-level relation of D2B times to be examined in the context of broader changes at the population level – Has the ability to study both these associations separately

Methods Estimate both individual and population-level components of the association between D2B time and mortality Analyzed in the context of patient-specific D2B time (i.e., the D2B time the individual patient experienced) Annual D2B time (i.e., the median D2B time in the year in which the PCI for that patient was done)

Results 150,116 pPCI procedures were done in 146,940 patients at 423 hospitals from 1/05-12/11 55% more patients underwent pPCI in 2011 than in 2005 Annual D2B times in the pPCI population decreased significantly from a median of 86 min in 2005 to 63 min in 2011 (p<0·0001). Unadjusted in-hospital mortality was 4.7% 6-month mortality was 13·5% in the cohort of patients aged 65 years or older (CMS cohort) Risk-adjusted mortality increased: – in-hospital mortality: non-significantly from 4.7% to 5.3%; p=0·06 – 6-month mortality: increased significantly from 12.9% to 14.4%; p=0·001

Predicted in-hospital and 6-month mortality across years related to secular trends at the population-level Predicted in-hospital mortality. Brahmajee K Nallamothu, Sharon-Lise T Normand, Yongfei Wang, Timothy P Hofer, John E Brush Jr, John C Messeng...

Relation between observed in-hospital mortality and annual D2B times across years (solid boxes) and deciles of patient-specific D2B times within years (open boxes). Brahmajee K Nallamothu, Sharon-Lise T Normand, Yongfei Wang, Timothy P Hofer, John E Brush Jr, John C Messeng...

Predicted in-hospital and 6-month mortality from the multilevel model over a range of patient-specific D2B times Brahmajee K Nallamothu, Sharon-Lise T Normand, Yongfei Wang, Timothy P Hofer, John E Brush Jr, John C Messeng...

D2B time, annual D2B time, and mortality In-hospital mortality6-month mortality Adjusted ORp valueAdjusted OR * * p value Patient-specific D2B times (per 10 min decrease) 0·92 (0·91–0·93)<0·00010·94 (0·93–0·95)<0·0001 Annual D2B times (per 1 year change) 1·12 (1·09–1·15)<0·00011·11 (1·07–1·14)<0·0001 Relation Between Patient-Specific D2B Time, Annual D2B time, and Mortality

Results The individual-level relation between D2B times and mortality showed that decreases in patient-specific D2B times were consistently associated with decreased in- hospital mortality within each year of the study period The population-level relation showed little correlation between decreases in annual D2B times and mortality across years Longer delays in patient-specific D2B time were associated with increasing mortality over the years of the study An increase in mortality was noted across years in the last decile of D2B times (longer times ): – in 2005 was 154 min with an unadjusted in-hospital mortality of 8·1% – in 2011 was 127 min with an unadjusted in-hospital mortality of 11·0%

Reasons for Differences In Results Why have decreases in mortality over time not occurred in the pPCI population despite reductions in D2B time? Expanding use of pPCI – the annual number of pPCIs reported within this cohort of hospitals increased by >50% between 2005 and 2011 – Estimates of pPCI use grew from 40% to 80% of patients with STEMI in the USA – While STEMI incidence decreased nationally Changing population of patients with STEMI undergoing the procedure

Conclusions The relationship between door to balloon time and mortality is complex and depends on: – Patient population: Transfers Cardiac arrest – Number and type of hospitals included – Changes in care over time Recent analyses indicate that Door to balloon time DOES matter! Better phrased, total time to reperfusion (direct presenter, EMS, transfers) is – Associated with lower mortality – Remains an appropriate goal for patients presenting with STEMI undergoing primary PCI – A key measure of performance, both at the hospital and the system